These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 24752799)

  • 21. Design, synthesis and evaluation of rivastigmine and curcumin hybrids as site-activated multitarget-directed ligands for Alzheimer's disease therapy.
    Li Y; Peng P; Tang L; Hu Y; Hu Y; Sheng R
    Bioorg Med Chem; 2014 Sep; 22(17):4717-25. PubMed ID: 25082512
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design, synthesis, biological evaluation, and molecular modeling of coumarin-piperazine derivatives as acetylcholinesterase inhibitors.
    Modh RP; Kumar SP; Jasrai YT; Chikhalia KH
    Arch Pharm (Weinheim); 2013 Nov; 346(11):793-804. PubMed ID: 24591157
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design, synthesis, and evaluation of indanone derivatives as acetylcholinesterase inhibitors and metal-chelating agents.
    Meng FC; Mao F; Shan WJ; Qin F; Huang L; Li XS
    Bioorg Med Chem Lett; 2012 Jul; 22(13):4462-6. PubMed ID: 22633691
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design, synthesis and biological evaluation of novel dual inhibitors of acetylcholinesterase and beta-secretase.
    Zhu Y; Xiao K; Ma L; Xiong B; Fu Y; Yu H; Wang W; Wang X; Hu D; Peng H; Li J; Gong Q; Chai Q; Tang X; Zhang H; Li J; Shen J
    Bioorg Med Chem; 2009 Feb; 17(4):1600-13. PubMed ID: 19162488
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design, synthesis, and molecular-modeling study of aminothienopyridine analogues of tacrine for Alzheimer's disease.
    Badran MM; Abdel Hakeem M; Abuel-Maaty SM; El-Malah A; Abdel Salam RM
    Arch Pharm (Weinheim); 2010 Oct; 343(10):590-601. PubMed ID: 20925094
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antioxidant and cholinesterase inhibitory activity of a new peptide from Ziziphus jujuba fruits.
    Zare-Zardini H; Tolueinia B; Hashemi A; Ebrahimi L; Fesahat F
    Am J Alzheimers Dis Other Demen; 2013 Nov; 28(7):702-9. PubMed ID: 24005854
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acetylcholinesterase inhibitors as Alzheimer therapy: from nerve toxins to neuroprotection.
    Singh M; Kaur M; Kukreja H; Chugh R; Silakari O; Singh D
    Eur J Med Chem; 2013; 70():165-88. PubMed ID: 24148993
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and biological evaluation of a new series of ebselen derivatives as glutathione peroxidase (GPx) mimics and cholinesterase inhibitors against Alzheimer's disease.
    Luo Z; Liang L; Sheng J; Pang Y; Li J; Huang L; Li X
    Bioorg Med Chem; 2014 Feb; 22(4):1355-61. PubMed ID: 24461494
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cholinesterase inhibitors: a patent review (2007 - 2011).
    de los Ríos C
    Expert Opin Ther Pat; 2012 Aug; 22(8):853-69. PubMed ID: 22764681
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis of imperatorin analogs and their evaluation as acetylcholinesterase and butyrylcholinesterase inhibitors.
    Granica S; Kiss AK; Jarończyk M; Maurin JK; Mazurek AP; Czarnocki Z
    Arch Pharm (Weinheim); 2013 Nov; 346(11):775-82. PubMed ID: 24123207
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design, synthesis, pharmacological evaluation, QSAR analysis, molecular modeling and ADMET of novel donepezil-indolyl hybrids as multipotent cholinesterase/monoamine oxidase inhibitors for the potential treatment of Alzheimer's disease.
    Bautista-Aguilera OM; Esteban G; Bolea I; Nikolic K; Agbaba D; Moraleda I; Iriepa I; Samadi A; Soriano E; Unzeta M; Marco-Contelles J
    Eur J Med Chem; 2014 Mar; 75():82-95. PubMed ID: 24530494
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis, biological assessment, and molecular modeling of racemic 7-aryl-9,10,11,12-tetrahydro-7H-benzo[7,8]chromeno[2,3-b]quinolin-8-amines as potential drugs for the treatment of Alzheimer's disease.
    Maalej E; Chabchoub F; Oset-Gasque MJ; Esquivias-Pérez M; González MP; Monjas L; Pérez C; de los Ríos C; Rodríguez-Franco MI; Iriepa I; Moraleda I; Chioua M; Romero A; Marco-Contelles J; Samadi A
    Eur J Med Chem; 2012 Aug; 54():750-63. PubMed ID: 22795665
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis, molecular modeling and evaluation of novel N'-2-(4-benzylpiperidin-/piperazin-1-yl)acylhydrazone derivatives as dual inhibitors for cholinesterases and Aβ aggregation.
    Özturan Özer E; Tan OU; Ozadali K; Küçükkılınç T; Balkan A; Uçar G
    Bioorg Med Chem Lett; 2013 Jan; 23(2):440-3. PubMed ID: 23273219
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis, design and biological evaluation of novel highly potent tacrine congeners for the treatment of Alzheimer's disease.
    Hamulakova S; Janovec L; Hrabinova M; Kristian P; Kuca K; Banasova M; Imrich J
    Eur J Med Chem; 2012 Sep; 55():23-31. PubMed ID: 22818849
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fluorinated benzophenone derivatives: balanced multipotent agents for Alzheimer's disease.
    Belluti F; De Simone A; Tarozzi A; Bartolini M; Djemil A; Bisi A; Gobbi S; Montanari S; Cavalli A; Andrisano V; Bottegoni G; Rampa A
    Eur J Med Chem; 2014 May; 78():157-66. PubMed ID: 24681980
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis, pharmacological assessment, and molecular modeling of 6-chloro-pyridonepezils: new dual AChE inhibitors as potential drugs for the treatment of Alzheimer's disease.
    Samadi A; de la Fuente Revenga M; Pérez C; Iriepa I; Moraleda I; Rodríguez-Franco MI; Marco-Contelles J
    Eur J Med Chem; 2013 Sep; 67():64-74. PubMed ID: 23838422
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and evaluation of tacrine-E2020 hybrids as acetylcholinesterase inhibitors for the treatment of Alzheimer's disease.
    Shao D; Zou C; Luo C; Tang X; Li Y
    Bioorg Med Chem Lett; 2004 Sep; 14(18):4639-42. PubMed ID: 15324879
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cannabinoid agonists showing BuChE inhibition as potential therapeutic agents for Alzheimer's disease.
    González-Naranjo P; Pérez-Macias N; Campillo NE; Pérez C; Arán VJ; Girón R; Sánchez-Robles E; Martín MI; Gómez-Cañas M; García-Arencibia M; Fernández-Ruiz J; Páez JA
    Eur J Med Chem; 2014 Feb; 73():56-72. PubMed ID: 24378710
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and evaluation of 7,8-dehydrorutaecarpine derivatives as potential multifunctional agents for the treatment of Alzheimer's disease.
    He Y; Yao PF; Chen SB; Huang ZH; Huang SL; Tan JH; Li D; Gu LQ; Huang ZS
    Eur J Med Chem; 2013 May; 63():299-312. PubMed ID: 23501115
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design, synthesis and evaluation of tacrine-flurbiprofen-nitrate trihybrids as novel anti-Alzheimer's disease agents.
    Chen Y; Sun J; Huang Z; Liao H; Peng S; Lehmann J; Zhang Y
    Bioorg Med Chem; 2013 May; 21(9):2462-70. PubMed ID: 23541836
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.